About Accelmed Ventures
Accelmed Ventures is a venture capital firm located in Tel Aviv, Israel. As of Jan 2020, Accelmed Ventures has invested in 7 companies. It primarily invests in Series A round in Israel based startups. Its investments are spread across a wide range of sectors from Life Sciences to High Tech and HealthTech. Most recently it participated in the $***** Series D round of BioProtect Overall, Accelmed Ventures portfolio has seen 4 acquisitions including key companies like BioProtect, Endospan and CartiHeal. A lot of funds co-invest with Accelmed Ventures, with names like KB Investment sharing a substantial percentage of its portfolio.Key Metrics
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Series C & 1 more
Portfolio Acquisitions
Portfolio Soonicorns
Accelmed Ventures' List of Top Investments
Accelmed Ventures has a portfolio of 7 companies. Their most notable investments are in Eximo Medical and Valcare Medical.Their portfolio spans across Israel and United States. They have invested in Life Sciences, High Tech, HealthTech and 2 other sectors, across stages such as Series A, Series C and 1 more. Here is the list of top investments by Accelmed Ventures:1. BioProtect
BioProtect is developing radiation protection technology. The company has developed a BioProtect/ ProSpace Balloon System which acts as a spacer and pushes healthy tissue away from the high-dose radiation field for patients receiving radiotherapy for prostate cancer.
Key facts about BioProtect
2. Endospan
EndoSpan is a VC backed pre-clinical stage medical device start-up developing an endovascular system for endovascular aortic aneurysm repair. The Nexus platform helps in optimizing the open-heart surgery to minimally invasive procedures by giving real-time insights on the aortic conditions. It has two stent graft systems - Horizon, and Nexus. Both products are in clinical development.
Key facts about Endospan
- Founded Year: 2009
- Location: Herzliya (Israel)
- Stage: Acquired
- Total Funding till date: $25M
- Employee Count: 65 as on Sep 30, 2026
- Investors: Accelmed, Arkin Holdings and 6 Others
- Latest Funding Round: Series C, Oct 21, 2015, $*****
- Highlight: Acquired
3. AiCure
Developer of an AI platform for patient engagement in clinical trials. The platform supports clinical trial participants through their smartphones, aiming to improve access and participation. It offers tools for capturing participant responses and managing adherence. The AI is designed to support various study models, including site-based, decentralized, virtual, and hybrid trials. Data collected can be used to support safety and efficacy endpoints.
Key facts about AiCure
- Founded Year: 2010
- Location: New York City (United States)
- Stage: Series C
- Total Funding till date: $55.8M
- Employee Count: 40 as on Sep 30, 2026
- Investors: Accelmed, New Leaf Venture Partners and 14 Others
- Latest Funding Round: Conventional Debt, Jan 23, 2024, $*****
- Highlight: Editors' Pick
Developer of minimally-invasive technologies for mitral regurgitation treatment and repair. The company focuses on a mitral valve treatment platform based on a D-shaped ring. This ring serves as a tool for mitral annulus repair. It also functions as a docking station for future technology. The company's management team includes experts in sales, finance, and cardiovascular devices.
Key facts about Valcare Medical
- Founded Year: 2012
- Location: Herzliya (Israel)
- Stage: Series B
- Total Funding till date: $28M
- Employee Count: 1 - 10 as on Jul 16, 2025
- Investors: Accelmed, Arkin Holdings and 3 Others
- Latest Funding Round: Series B, Sep 2018, $*****
- Highlight: Editors' Pick
5. CartiHeal
CartiHeal provides of implant for bone and cartilage regeneration. The company has developed a cell-free implant Agili-C that enables bone and cartilage regeneration in a single-step procedure. Agili-C is CE marked for the treatment of focal articular cartilage and osteochondral defects.
Key facts about CartiHeal
- Founded Year: 2009
- Location: Kfar Saba (Israel)
- Stage: Acquired
- Total Funding till date: $65.8M
- Employee Count: 15 as on Sep 30, 2026
- Investors: Accelmed, Arkin Holdings and 8 Others
- Latest Funding Round: Series D, Jul 16, 2020, $*****
- Highlight: Acquired
Accelmed Ventures' Year-on-Year Investment Trends
Accelmed Ventures has invested in 7 companies over the last 14 years, with an average of 0 new investment annually in the last 10 years. Its most recent first time investment was in BioProtect and most recent follow-on round was in CartiHeal.Accelmed Ventures' Investments by Stage
Accelmed Ventures has made 4 investments in Series A stage with an average round size of $10.9M, 2 investments in Series C stage with an average round size of $17.2M and 1 investment in Series D stage with an average round size of $13M.Stage of entry | No. of Investments |
|---|---|
Series A | 4 |
Series C | 2 |
Series D | 1 |
Note: We have considered here, only first round of investments
Accelmed Ventures' Investments by Sector
Accelmed Ventures has a diverse portfolio, with companies operating in the Life Sciences, Enterprise Applications, HealthTech, Artificial Intelligence - Industry Applications and Healthcare. Notably, it has invested in 7 Enterprise (B2B) companies, 7 Tech companies, 2 Software companies and at least 2 companies focusing on Tech hardware.Sector | No. of Investments |
|---|---|
Life Sciences | 6 |
Enterprise Applications | 2 |
HealthTech | 2 |
Artificial Intelligence - Industry Applications | 1 |
Healthcare | 1 |
Others | 2 |
Note: We have considered here, only first round of investments
Accelmed Ventures' Investments by Geography
Accelmed Ventures has made most investments in Israel (5), followed by United States where it has made 2 investments.Country | No. of Investments |
|---|---|
Israel | 5 |
United States | 2 |
Note: We have considered here, only first round of investments
Accelmed Ventures' recent investments
Accelmed Ventures has not made any investment in 2026 so far.Here are the most recent investments by Accelmed Ventures:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Jan 15, 2020 | Israel | Series D | 7100 | ||
Nov 13, 2019 | United States | Series A | 5204 | [+7] | |
Nov 07, 2019 | United States | Series C | 3843 | ||
Jan 11, 2016 | Israel | Series B | 2086 | ||
Oct 21, 2015 | Israel | Series C | 3954 |
Acquired companies in Accelmed Ventures' Portfolio
4 companies from Accelmed Ventures' portfolio have been acquired. The most recent acquisition was BioProtect in May 2026 by Olympus for $*****.Here are Accelmed Ventures' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
May 26, 2026 | Jan 15, 2020 | Series D | 4236 | |
May 18, 2026 | Oct 21, 2015 | Series C | 9178 | |
Nov 22, 2023 | Feb 01, 2012 | Series A | 2830 | |
Oct 03, 2019 | Jul 29, 2015 | Series A | 3305 |
Co-investors of Accelmed Ventures
Over the past 14 years, 53 investors have co-invested in Accelmed Ventures's portfolio companies. This includes funds and angels.
- Invested before Accelmed Ventures: Xenia Venture Capital, NCATS and 6 others have invested in rounds before Accelmed Ventures. There is 1 company where Xenia Venture Capital has invested before Accelmed Ventures and 1 company where NCATS has invested before Accelmed Ventures.
- Top Co-investors of Accelmed Ventures: 21 investors entered a company along with Accelmed Ventures. These include investors like KB Investment (1 company).
- Invested after Accelmed Ventures: A total of 24 investors have invested in Accelmed Ventures's portfolio after their investments. Top Investors include Peregrine Ventures (2 companies), Vincent Tchenguiz (1 company) and Almeda Ventures (1 company).
Recent News related to Accelmed Ventures
•
BioProtect Announces Initial Closing of Equity FinancingPR Newswire•Jan 14, 2020•BioProtect, Accelmed Ventures, KB Investment, Consensus Business Group and 1 other
